SCHEMBL31663548

SCHEMBL31663548

Cc1cc(-c2cc(C#N)c(-c3ccccc3)c(-c3ccccc3)c2)cc(C)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.49
KDM4E B2RXH2 5/20 0.49
HPGD P15428 4/20 0.49
CYP1A2 P05177 3/20 0.49
CYP2C9 P11712 3/20 0.49
CYP2C19 P33261 3/20 0.49
HSD17B10 Q99714 3/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GAA P10253 2/20 0.46
GALR3 O60755 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GLA P06280 2/20 0.44
MAPK1 P28482 1/20 0.44
XDH P47989 1/20 0.41
ABCG2 Q9UNQ0 3/20 0.41
HTT P42858 2/20 0.40
GRM5 P41594 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663512 0.83 ADORA1 (0.49) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663543 0.83 CYP1A2 (0.51) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663529 0.83 TGFBR1 (0.46) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663532 0.81 NPSR1 (0.44) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663614 0.80 AR (0.48) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663633 0.80 PIK3CA (0.48) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663547 0.79 KMT2A (0.48) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL31663569 0.78 CYP11B2 (0.47) ALDH1A1KDM4ECYP1A2NPSR1GAA
SCHEMBL24449126 0.74 LMNA (0.46) ALDH1A1KDM4EHPGDCYP1A2CYP2C9
SCHEMBL24449121 0.74 LMNA (0.46) ALDH1A1KDM4EHPGDCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885KDM4E 4364/4885HPGD 2163/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885KDM4E 4364/4885HPGD 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.